Delivery Order SPE2DB24D1007-SPE2DB25FCBTF
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,073.80 to AmerisourceBergen Drug Corp for AJOVY 225 mg/1.5 mL auto-injector units on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order, which is not subject to a set-aside designation, represents a competitive award for pharmaceutical supply to support federal medical procurement needs. The product will be delivered to AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $2,597.47 to AmerisourceBergen Drug Corp for AJOVY 225 mg/1.5 ml auto-injector units, with an ultimate completion date of September 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive award practices. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery...
- The Defense Logistics Agency awarded a $6,655.88 delivery order to AmerisourceBergen Drug Corp for AJOVY 225 mg/1.5 mL auto-injector units, with a completion date of September 30, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and is registered in the System for Award Management. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $6,017.34 to AmerisourceBergen Drug Corp for the supply of AJOVY 225 mg/1.5 mL auto-injector units. This firm fixed-price delivery order, issued on September 29, 2025, represents a non-set-aside, competitively awarded contract with an ultimate completion date of September 30, 2025. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen...
- The Defense Logistics Agency awarded a $1,820.00 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of AJOVY 225 mg/1.5 ml auto-injector units. The contract, which carries no set-aside designation, represents a competitively awarded order with an ultimate completion date of September 15, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,847.18 to AmerisourceBergen Drug Corp's Corporate Office Division for the supply of AJOVY 225 MG/1.5 ML AUTOINJECT 1.5ML, a pharmaceutical product. This order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which provides a comprehensive range of medical commodities to support military treatment programs and facilities...
- The Defense Logistics Agency awarded a delivery order valued at $4,840.30 to AmerisourceBergen Drug Corp for the supply of AJOVY (fremanezumab) 225 mg/1.5 mL auto-injector units. This contract, issued on October 8, 2025, with an ultimate completion date of October 9, 2025, represents a firm fixed-price delivery order with no set-aside designation. The award is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, the company's headquarters location. This...
- The Defense Logistics Agency (DLA) awarded a $1,943.71 firm fixed price delivery order to AmerisourceBergen Drug Corp for AJOVY (fremanezumab) 225 mg/1.5 mL syringes on September 26, 2025, with completion targeted for September 29, 2025. This non-set-aside award represents a pediatric migraine prevention medication delivery to support federal medical supply requirements. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $1,092.00 to AmerisourceBergen Drug Corp for AJOVY 225 mg/1.5 mL auto-injector pens on September 24, 2025, with completion scheduled for September 25, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $1,092.00 to AmerisourceBergen Drug Corp for the supply of Ajovy 225 mg/1.5 mL auto-injector pens. The contract, which was competitively awarded without set-aside designation, was finalized on September 24, 2025, with an ultimate completion date of September 25, 2025. Performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- SPE2DB24D1007Indefinite Delivery Contract
- SPE2DB24D1007-SPE2DB25FCBTFDelivery Order
The Defense Logistics Agency (DLA) awarded a $1,092.00 delivery order to AmerisourceBergen Drug Corp for AJOVY 225 mg/1.5 mL auto-injector units, a pharmaceutical product used in the treatment of chronic migraine. This competitively awarded, firm fixed-price contract was issued on May 12, 2025, with an ultimate completion date of May 13, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a non-set-aside procurement, this order demonstrates AmerisourceBergen's continued capability to meet federal pharmaceutical supply requirements through open competition. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract number SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive prime vendor contract enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs and other federal agencies, including the Defense Health Agency and U.S. Coast Guard. The company's pharmaceutical distribution capabilities across multiple therapeutic domains position it as a critical vendor within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 5/12/25 |